Group 1 - TOMI Environmental Solutions, Inc. will present at the LD Micro Main Event XIX on October 21, 2025, at 10:00 AM PT [1][2] - The event will take place from October 19 to 21, 2025, at the Hotel del Coronado in San Diego, California, featuring around 120 companies [3][4] - Dr. Halden Shane, CEO and Chairman of the Board, will be delivering the presentation for TOMI [1] Group 2 - TOMI specializes in disinfection and decontamination through its Binary Ionization Technology (BIT) platform, marketed under the SteraMist brand [5] - The BIT solution utilizes a low percentage of hydrogen peroxide as its active ingredient, employing patented ionized Hydrogen Peroxide (iHP) technology for superior disinfection [5] - TOMI's products are designed for a wide range of applications, including hospitals, biosafety labs, pharmaceutical facilities, and various commercial settings [5]

Core Insights - TOMI Environmental Solutions, Inc. has appointed Mr. Harold W. Paul to its Board of Directors, effective immediately, succeeding Ms. Kelly J. Anderson who resigned as of September 30, 2025 [1][3] Company Overview - TOMI Environmental Solutions, Inc. specializes in disinfection and decontamination through its Binary Ionization Technology (BIT) platform, marketed under the SteraMist brand [1][4] - The BIT solution utilizes a low percentage of hydrogen peroxide as its active ingredient and employs patented ionized Hydrogen Peroxide (iHP) technology for superior disinfection [4] Leadership Experience - Mr. Paul brings over 40 years of legal and securities expertise, along with extensive board leadership experience across various industries, having previously served on TOMI's Board from 2009 to 2021 [2] - He has advised numerous publicly traded companies as outside legal counsel and has served on the boards of six public companies [2] Strategic Importance - The CEO of TOMI, Dr. Halden Shane, expressed that Mr. Paul's knowledge of securities law and corporate governance will provide valuable insights as the company advances its strategy and expands its impact in critical industries [3]

Core Insights - TOMI Environmental Solutions, Inc. has appointed Mr. Francesco Fragasso to its Board of Directors, effective immediately, succeeding Mr. Walter Johnsen who has resigned [1][2][4] Company Overview - TOMI Environmental Solutions, Inc. specializes in disinfection and decontamination through its Binary Ionization Technology (BIT) platform, marketed under the SteraMist brand [5] - The BIT solution utilizes a low percentage of hydrogen peroxide as its active ingredient and employs patented ionized Hydrogen Peroxide (iHP) technology for superior disinfection [5] Leadership Experience - Mr. Fragasso brings over 25 years of global financial and operational leadership experience across various industries, having served as CFO for multiple companies including Hamilton Thorne Ltd. and Fluence Corporation Ltd. [3] - He is a European Chartered Public Accountant and holds an MBA from Boston University, along with a Bachelor and Master of Science in Business and Economics from Università Bocconi in Milan, Italy [3] Strategic Importance - The CEO of TOMI, Dr. Halden Shane, emphasized that Mr. Fragasso's extensive experience in guiding innovative companies through growth and transformation will be a significant asset for TOMI as it continues to expand its presence across multiple industries [4]

Core Insights - TOMI Environmental Solutions, Inc. is participating in the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2025 on September 16 and 17, 2025, with a presentation by CEO Dr. Halden Shane [1] - The company specializes in disinfection and decontamination through its Binary Ionization Technology (BIT) platform, marketed under the SteraMist brand [4] Company Overview - TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) focuses on providing environmental solutions for disinfection, utilizing its BIT platform, which was developed with the Defense Advanced Research Projects Agency (DARPA) [4] - The BIT solution employs a low percentage of hydrogen peroxide as its active ingredient, utilizing patented ionized Hydrogen Peroxide (iHP) technology for superior disinfection [4] - TOMI's products cater to a wide range of sectors, including hospitals, biosafety labs, pharmaceutical facilities, commercial buildings, schools, and emergency services [4] Conference Details - The live webcast of TOMI's presentation will be available online, with a replay accessible afterward [2] - The iAccess Alpha conference features companies recommended by investors, providing opportunities for one-on-one meetings with TOMI [3]

Core Insights - TOMI Environmental Solutions, Inc. reported a 42% increase in revenue for Q1 2025 compared to the previous quarter, driven by strong demand for its product lines and recurring solution sales [2][3] - The company achieved a gross margin of 60.4%, slightly up from 60.2% in the prior year, and reduced its operating loss to $(754,000) from $(1,226,000) year-over-year [6] - Net loss decreased to $(256,000) or $(0.01) per share, compared to $(1,310,000) or $(0.07) per share in the same period last year [6] Financial Performance - Net sales for Q1 2025 were $1,577,000, up from $1,114,000 in Q1 2024, marking a significant year-over-year growth [6] - SteraMist product-based revenues increased to $1,000,000 from $743,000, reflecting a $257,000 rise due to heightened demand for various SteraMist solutions [6] - Service-based revenue also grew by 56%, reaching $577,000 compared to $371,000 in the prior year [6] Market Trends and Business Development - Domestic revenue surged by 80% to $1,192,000 from $662,000, attributed to increased demand for solutions and services [6] - The sales backlog as of March 31, 2025, was $1,225,000, an increase of $348,000 from December 31, 2024 [6] - A significant contract was secured for a SteraMist iHP Custom Engineered System at a university in Rhode Island, valued at approximately $450,000 [6] Strategic Partnerships and Expansion - TOMI announced the deployment of SteraMist iHP technology at NASA Johnson Space Center, indicating expansion into the aerospace sector [6] - An OEM partnership with Pharma Biotech System Components was established to enhance the SteraMist Integrated System [6] - The company is expanding into aquaculture with a new partner, Algafeed, further diversifying its market reach [7]

Core Insights - TOMI Environmental Solutions, Inc. reported a 5% year-over-year increase in annual revenue for 2024, reaching $7.739 million compared to $7.355 million in 2023, while also expanding its customer base and product line [2][8] - The company experienced a GAAP net loss of $4.477 million for the year, compared to a loss of $3.403 million in the previous year, but noted improvements in non-GAAP financials, with a non-GAAP net loss of $2.050 million compared to $2.838 million in 2023 [3][4][8] - Preliminary Q1 2025 revenues are up 42% compared to Q1 2024, indicating a strong start to the year and a robust sales pipeline [2][16] Financial Performance - For the fourth quarter of 2024, net sales were $1.069 million, down from $1.528 million in Q4 2023, with a GAAP gross margin of -49.5% compared to 54.9% in the prior year [3][8] - Non-GAAP gross sales for Q4 2024 were $1.296 million, down from $1.656 million in Q4 2023, with a non-GAAP gross margin of 54.2% compared to 58.4% in the same period last year [4][8] - The total operating loss for the year was $4.105 million, compared to $3.349 million in 2023, while the non-GAAP operating loss improved to $1.678 million from $2.785 million [3][4][8] Business Highlights - SteraMist product-based revenues increased to $6.035 million in 2024 from $5.781 million in 2023, driven by higher demand for mobile and SIS units [8] - Service-based revenue also grew to $1.704 million in 2024 from $1.574 million in 2023, attributed to increased demand for iHP services [8] - International revenue grew by 33% in 2024, with new customers in Canada, South Africa, and India, and the company has established partnerships across various regions [8] Future Outlook - The company anticipates continued improvement in profitability throughout 2025, supported by high gross margins and a reduced expense structure [2][7] - Sales backlog increased to $1.232 million as of March 31, 2025, reflecting a 40% increase from December 31, 2024 [16] - The company is committed to nurturing partnerships with over 30 partners globally to strengthen the SteraMist brand [8]